Report cover image

Platelet Rich Plasma Market Size: Global Industry Growth, Share, Analysis and Forecast 2020-2032

Publisher Acumen Research and Consulting
Published Mar 24, 2024
Length 250 Pages
SKU # ACRC19213290

Description

The Platelet Rich Plasma Market Size accounted for USD 574.3 Million in 2023 and is estimated to achieve a market size of USD 1676.3 Million by 2032 growing at a CAGR of 12.6% from 2024 to 2032.




The Platelet Rich Plasma (PRP) Market has garnered significant attention in recent years due to its promising applications in regenerative medicine, orthopedics, dermatology, and aesthetics. PRP therapy, which involves concentrating platelets from a patient's own blood to harness growth factors and proteins that promote healing, has emerged as a minimally invasive treatment option for various conditions, including musculoskeletal injuries, hair loss, and skin rejuvenation. This market is poised for substantial growth, driven by an increasing emphasis on non-surgical treatment modalities, rising awareness of the benefits of regenerative therapies, and a growing number of clinical studies supporting PRP’s efficacy.

Technological advancements in blood processing techniques are enhancing the efficiency and safety of PRP preparations. Innovations such as automated PRP systems and advanced centrifugation technologies are streamlining the separation process, leading to higher quality PRP products. Additionally, the growing acceptance of PRP therapy among healthcare providers and patients, coupled with its application in diverse fields—from sports medicine to cosmetic procedures—further contributes to market expansion.

Geographically, North America dominates the PRP market, driven by a robust healthcare infrastructure, significant investments in research and development, and increasing adoption of regenerative therapies. However, the Asia-Pacific region is emerging as a significant player, propelled by rapid advancements in healthcare technologies, rising disposable incomes, and increasing patient populations seeking alternative treatment options.

Despite its growth potential, the PRP market faces challenges such as regulatory uncertainties, variations in PRP preparation protocols, and concerns regarding the standardization of treatment practices. Furthermore, while many studies demonstrate the benefits of PRP, ongoing research is necessary to establish comprehensive guidelines and optimize treatment protocols across various applications.

Platelet Rich Plasma Market Segmentation

The worldwide market for platelet rich plasma is split based on product, type, application, and geography.

Platelet Rich Plasma PRP Market By Product

Pure Platelet-Rich Plasma
Leukocyte Platelet-Rich Plasma
Pure Platelet-Rich Fibrin
Leukocyte Platelet-Rich Fibrin

Platelet Rich Plasma PRP Market By Type

Autologous Platelet-Rich Plasma
Allogeneic Platelet-Rich Plasma
Homologous Platelet-Rich Plasma

Platelet Rich Plasma PRP Market By Application

Cosmetic Surgery
Orthopedic Surgery
Ophthalmic Surgery
Dentistry
Cardiac Surgery
Neurosurgery
Others

Platelet Rich Plasma Market Regional Outlook

North America
U.S.
Canada

Europe

U.K.
Germany
France
Spain
Rest of Europe

Asia-Pacific

India
Japan
China
Australia
South Korea
Rest of Asia-Pacific

Latin America

Brazil
Mexico
Rest of Latin America

The Middle East & Africa

South Africa
GCC Countries
Rest of the Middle East & Africa (ME&A)

Platelet Rich Plasma Market Players
Some of the top platelet rich plasma companies offered in our report includes APEX Biologix, Arthrex, Inc., Celling BioSciences, Dr. PRP America, LLC, EmCyte Corporation, Glofinn Oy, Johnson & Johnson (DePuy Synthes), Juventix, Stryker, T-Biotechnology (T-LAB), Terumo BCT, Inc., and Zimmer Biomet.

Table of Contents

250 Pages
CHAPTER 1. Industry Overview of Platelet Rich Plasma Market
1.1. Definition and Scope
1.1.1. Definition of Platelet Rich Plasma
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Platelet Rich Plasma Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Platelet Rich Plasma Market By Product
1.2.3. Platelet Rich Plasma Market By Type
1.2.4. Platelet Rich Plasma Market By Application
1.2.5. Platelet Rich Plasma Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Platelet Rich Plasma Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Platelet Rich Plasma Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2023
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2023
4.2. R&D Status of Major Manufacturers in 2023
CHAPTER 5. Platelet Rich Plasma Market By Product
5.1. Introduction
5.2. Platelet Rich Plasma Revenue By Product
5.2.1. Platelet Rich Plasma Revenue (USD Million) and Forecast, By Product, 2020-2032
5.2.2. Pure Platelet-Rich Plasma
5.2.2.1. Pure Platelet-Rich Plasma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Leukocyte Platelet-Rich Plasma
5.2.3.1. Leukocyte Platelet-Rich Plasma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.4. Pure Platelet-Rich Fibrin
5.2.4.1. Pure Platelet-Rich Fibrin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.5. Leukocyte Platelet-Rich Fibrin
5.2.5.1. Leukocyte Platelet-Rich Fibrin Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Platelet Rich Plasma Market By Type
6.1. Introduction
6.2. Platelet Rich Plasma Revenue By Type
6.2.1. Platelet Rich Plasma Revenue (USD Million) and Forecast, By Type, 2020-2032
6.2.2. Autologous Platelet-Rich Plasma
6.2.2.1. Autologous Platelet-Rich Plasma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Allogeneic Platelet-Rich Plasma
6.2.3.1. Allogeneic Platelet-Rich Plasma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Homologous Platelet-Rich Plasma
6.2.4.1. Homologous Platelet-Rich Plasma Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Platelet Rich Plasma Market By Application
7.1. Introduction
7.2. Platelet Rich Plasma Revenue By Application
7.2.1. Platelet Rich Plasma Revenue (USD Million) and Forecast, By Application, 2020-2032
7.2.2. Cosmetic Surgery
7.2.2.1. Cosmetic Surgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Orthopedic Surgery
7.2.3.1. Orthopedic Surgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Ophthalmic Surgery
7.2.4.1. Ophthalmic Surgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.5. Dentistry
7.2.5.1. Dentistry Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.6. Cardiac Surgery
7.2.6.1. Cardiac Surgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.7. Neurosurgery
7.2.7.1. Neurosurgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.8. Neurosurgery
7.2.8.1. Neurosurgery Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. North America Platelet Rich Plasma Market By Country
8.1. North America Platelet Rich Plasma Market Overview
8.2. U.S.
8.2.1. U.S. Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
8.2.2. U.S. Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
8.2.3. U.S. Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
8.3. Canada
8.3.1. Canada Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
8.3.2. Canada Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
8.3.3. Canada Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
8.4. North America PEST Analysis
CHAPTER 9. Europe Platelet Rich Plasma Market By Country
9.1. Europe Platelet Rich Plasma Market Overview
9.2. U.K.
9.2.1. U.K. Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
9.2.2. U.K. Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
9.2.3. U.K. Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
9.3. Germany
9.3.1. Germany Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
9.3.2. Germany Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
9.3.3. Germany Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
9.4. France
9.4.1. France Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
9.4.2. France Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
9.4.3. France Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
9.5. Spain
9.5.1. Spain Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
9.5.2. Spain Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
9.5.3. Spain Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
9.6. Rest of Europe
9.6.1. Rest of Europe Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
9.6.2. Rest of Europe Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
9.6.3. Rest of Europe Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
9.7. Europe PEST Analysis
CHAPTER 10. Asia Pacific Platelet Rich Plasma Market By Country
10.1. Asia Pacific Platelet Rich Plasma Market Overview
10.2. China
10.2.1. China Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
10.2.2. China Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
10.2.3. China Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
10.3. Japan
10.3.1. Japan Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
10.3.2. Japan Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
10.3.3. Japan Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
10.4. India
10.4.1. India Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
10.4.2. India Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
10.4.3. India Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
10.5. Australia
10.5.1. Australia Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
10.5.2. Australia Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
10.5.3. Australia Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
10.6. South Korea
10.6.1. South Korea Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
10.6.2. South Korea Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
10.6.3. South Korea Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
10.7. Rest of Asia-Pacific
10.7.1. Rest of Asia-Pacific Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
10.7.2. Rest of Asia-Pacific Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
10.7.3. Rest of Asia-Pacific Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
10.8. Asia Pacific PEST Analysis
CHAPTER 11. Latin America Platelet Rich Plasma Market By Country
11.1. Latin America Platelet Rich Plasma Market Overview
11.2. Brazil
11.2.1. Brazil Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
11.2.2. Brazil Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
11.2.3. Brazil Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
11.3. Mexico
11.3.1. Mexico Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
11.3.2. Mexico Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
11.3.3. Mexico Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
11.4. Rest of Latin America
11.4.1. Rest of Latin America Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
11.4.2. Rest of Latin America Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
11.4.3. Rest of Latin America Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
11.5. Latin America PEST Analysis
CHAPTER 12. Middle East & Africa Platelet Rich Plasma Market By Country
12.1. Middle East & Africa Platelet Rich Plasma Market Overview
12.2. GCC
12.2.1. GCC Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
12.2.2. GCC Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
12.2.3. GCC Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
12.3. South Africa
12.3.1. South Africa Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
12.3.2. South Africa Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
12.3.3. South Africa Platelet Rich Plasma Revenue (USD Million) and Forecast By Type, 2020-2032
12.4. Rest of Middle East & Africa
12.4.1. Rest of Middle East & Africa Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
12.4.2. Rest of Middle East & Africa Platelet Rich Plasma Revenue (USD Million) and Forecast By Application, 2020-2032
12.4.3. Rest of Middle East & Africa Platelet Rich Plasma Revenue (USD Million) and Forecast By Product, 2020-2032
12.5. Middle East & Africa PEST Analysis
CHAPTER 13. Player Analysis Of Platelet Rich Plasma Market
13.1. Platelet Rich Plasma Market Company Share Analysis
13.2. Competition Matrix
13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
13.2.2. New Product Launches and Product Enhancements
13.2.3. Mergers And Acquisition In Global Platelet Rich Plasma Market
13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 14. Company Profile
14.1. APEX Biologix
14.1.1. Company Snapshot
14.1.2. Business Overview
14.1.3. Financial Overview
14.1.3.1. Revenue (USD Million), 2023
14.1.3.2. APEX Biologix 2023 Platelet Rich Plasma Business Regional Distribution
14.1.4. Product /Service and Specification
14.1.5. Recent Developments & Business Strategy
14.2. Arthrex, Inc.
14.3. Celling BioSciences
14.4. Dr. PRP America, LLC
14.5. EmCyte Corporation
14.6. Glofinn Oy
14.7. Johnson & Johnson (DePuy Synthes)
14.8. Juventix, Stryker
14.9. T-Biotechnology (T-LAB)
14.10. Terumo BCT, Inc.
14.11. Zimmer Biomet

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us